Home > Publications > METRIC Study Group. Improved survival with MEK inhibition in BRAF-mutated melanoma.

METRIC Study Group. Improved survival with MEK inhibition in BRAF-mutated melanoma.

Flaherty, K.T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., Demidov, L.V., Hassel, J.C. Rutkowski, P., Mohr, P., Dummer, R., Trefzer, U., Larkin, J.M., Utikal, J., Dreno, B., Nyakas, M., Middleton, M.R., Becker, J.C., Casey, M., Sherman, L.J., Wu, F.S., Ouellet, D., Martin, A.M., Patel, K., Schadendorf., D.

New England Journal of Medicine Jul 12;367(2):107-14.

Date: 0